CompaniesVIMRx Pharmaceuticals

VIMRx Pharmaceuticals

defunct

About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (2)

Total Trials

2

As Lead Sponsor

0

As Collaborator

2

Total Enrollment

56

By Phase

PHASE1: 2

By Status

COMPLETED: 2

Clinical Trials Pipeline

No trials with date information available

Recent Trials

NCT00000645Collaborator

A Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less Than 300 CD4 Lymphocytes

PHASE1Completed

32 participants

NCT00000792Collaborator

A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected Subjects

PHASE1Completed

24 participants

Funding History (19)

8-K

Dec 18, 2002

DEF 14C

Nov 25, 2002

8-K

Nov 4, 2002

8-K

Oct 18, 2002

8-K

Aug 30, 2002

8-K

Aug 14, 2002

8-K

Sep 17, 2001

8-K

Aug 9, 2001

8-K

Jun 14, 2001

DEF 14A

Apr 30, 2001